Photo of University Hall

View Profile Page

Faculty/Staff Login:

Carlos Molina

Professor, Biology

Email:
molinac@montclair.edu
Phone:
973-655-3302
Degrees:
BS, University of Puerto Rico, Rio Piedras
MS, Purdue University
PhD, Purdue University
vCard:
Download vCard

Profile

Dr. Carlos A. Molina is a Professor of Molecular Biology at the College of Sciences and Mathematics of Montclair State University. From 1994 to 2006 he was an assistant professor at the Department of Obstetrics, Gynecology and Women’s Health at Rutgers Medical School in Newark, NJ.
Dr. Molina received his B.S. in Biology from the University of Puerto Rico, M.S. and Ph.D. in Biochemistry for Purdue University and postdoctoral training in molecular and cell biology at the University of Louis Pasteur in Strasbourg, France.

Using zebrafish as a model organism, Dr. Molina has focused his research in two areas, cancer and the female reproductive system. In the area of cancer research he seeks to understand the mechanisms involved in eliminating and misplacing a protein with tumor suppression activity in skin cancer cells. This data set the stage to test for pharmacological agents specifically targeted to inhibit the degradation and abnormal localization of this protein.

In the area of reproductive biology he is developing ovarian-specific transgenic zebrafish to dissect the molecular mechanisms of ovulation. These studies may lead to the development of new technologies in the field of agricultural livestock, where higher ovulation rates are desired. Further research in this area could also lead to the development of novel reproductive technologies.

Dr. Molina was the recipient several honors and grants from the American Association of Cancer Research, National Health Institute, National Science Foundation. He has been a member of the National Institutes of Health National Heart, Lung and Blood Institute and Department of Defense Ovarian and Prostate Cancer Study Sections.

Dr. Molina presently have two active grants.

1) National Institute of Health/National Institute of General Medical Sciences, USA. SC1GM125583 “Post-translational Regulation of Inducible cAMP Early Repressor and its Implications in Cancer”
May 1, 2018 – April 30, 2022. $1,297,953.

2) National Science Foundation, USA. Award Number (FAIN): 1952513 “IRES Track 1: US-Japan study of novel genetic elements regulating seasonal behavior of medaka fish” September 1, 2021-August 31, 2024. $300,000.


Office Hours: Tuesday and Thursday from 3:30-5:00 PM
Center for Environmental and Life Sciences (CELS) 400
or Zoom https://montclair.zoom.us/j/8353259292

Specialization

Cancer Research
Biology of Reproduction

Resume/CV

Office Hours

Fall

Tuesday
3:30 pm - 5:00 pm
Dr. Carlos Molina's Personal Meeting Room https://montclair.zoom.us/j/8353259292
Thursday
3:30 pm - 5:00 pm
Dr. Carlos Molina's Personal Meeting Room https://montclair.zoom.us/j/8353259292

Spring

Tuesday
3:30 pm - 5:00 pm
Dr. Carlos Molina's Personal Meeting Room https://montclair.zoom.us/j/8353259292
Thursday
3:30 pm - 5:00 pm
Dr. Carlos Molina's Personal Meeting Room https://montclair.zoom.us/j/8353259292

Links

Research Projects

Cancer and Reproductive Biology

Dr. Molina has focused his research in two areas, cancer and biology of reproduction. In the area of cancer research he seeks to understand the mechanisms involved in eliminating and misplacing a protein with tumor suppression activity using a zebrafish model for melanoma as a paradigm for cancer. This data set the stage to test for pharmacological agents specifically targeted to inhibit the degradation and abnormal localization of this protein. Restoring the function of a misplaced tumor suppressor protein maybe an important anticancer therapy opportunity.
In the area of reproductive biology he is developing an ovarian-specific transgenic zebrafish to dissect the molecular mechanisms of ovulation. These studies may lead to the development of new technologies in the field of agricultural livestock, where higher ovulation rates are desired. Further research in this area could also lead to the development of novel reproductive technologies.